Novartis cuts CCO title as international chief Marie-France
By A Mystery Man Writer
Description
Just as Novartis’ C-suite appeared to have stabilized amid a major overhaul of the company, the Swiss pharma is losing its international markets leader and getting rid of its chief commercial offic | Just as Novartis’ C-suite appeared to have stabilized amid a major overhaul of the company, the Swiss pharma is losing its international markets leader and getting rid of its chief commercial officer title.
Xenotransplant gene editor eGenesis snags transplant expert as CMO; John Tsai, Susanne Schaffert among the hard cuts made at Novartis - ECHEMI
424B4
The 47th Annual Meeting of the European Society for Blood and Marrow Transplantation: Physicians – Poster Session (P001 – P182)
Tschudin Facebook, Instagram & Twitter on PeekYou
Novartis: Novartis names new board member after international boss
Document
Novartis names new board member after international boss steps down
Medicine – sciencesprings
Evidence-based clinical guidelines for immigrants and refugees
Executives Fierce Pharma
from
per adult (price varies by group size)